Literature DB >> 30631881

Clinics in diagnostic imaging (193). Sporadic Creutzfeldt-Jakob disease (sCJD).

Jun Si Yuan Li1, Kheng Choon Lim1, Winston Eng Hoe Lim1, Robert Chun Chen1.   

Abstract

A 68-year-old man presented with a three-week history of rapidly progressive dementia, gait ataxia and myoclonus. Subsequent electroencephalography showed periodic sharp wave complexes, and cerebrospinal fluid assay revealed the presence of a 14-3-3 protein. A probable diagnosis of sporadic Creutzfeldt-Jakob disease was made, which was further supported by magnetic resonance (MR) imaging of the brain showing asymmetric signal abnormality in the cerebral cortices and basal ganglia. The aetiology, clinical features, diagnostic criteria, various MR imaging patterns and radiologic differential diagnosis of sporadic Creutzfeldt-Jakob disease are discussed in this article. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  Creutzfeldt-Jakob disease; MR imaging; human prion disease

Mesh:

Year:  2018        PMID: 30631881      PMCID: PMC6301874          DOI: 10.11622/smedj.2018146

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  16 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

3.  Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt-Jakob disease.

Authors:  Sanjay Mittal; Peter Farmer; Peter Kalina; Peter B Kingsley; John Halperin
Journal:  Arch Neurol       Date:  2002-01

4.  MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis.

Authors:  A L Kotsenas; R E Watson; S J Pittock; J W Britton; S L Hoye; A M L Quek; C Shin; C J Klein
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

Review 5.  The role of neuroimaging in evaluating patients affected by Creutzfeldt-Jakob disease: a systematic review of the literature.

Authors:  Federico Caobelli; Milena Cobelli; Claudio Pizzocaro; Marco Pavia; Silvia Magnaldi; Ugo Paolo Guerra
Journal:  J Neuroimaging       Date:  2014-03-05       Impact factor: 2.486

6.  Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

Authors:  M Pocchiari; M Puopolo; E A Croes; H Budka; E Gelpi; S Collins; V Lewis; T Sutcliffe; A Guilivi; N Delasnerie-Laupretre; J-P Brandel; A Alperovitch; I Zerr; S Poser; H A Kretzschmar; A Ladogana; I Rietvald; E Mitrova; P Martinez-Martin; J de Pedro-Cuesta; M Glatzel; A Aguzzi; S Cooper; J Mackenzie; C M van Duijn; R G Will
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

Review 7.  Imaging of Herpesvirus Infections of the CNS.

Authors:  Bruno P Soares; James M Provenzale
Journal:  AJR Am J Roentgenol       Date:  2016-01       Impact factor: 3.959

Review 8.  Prions.

Authors:  S B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

9.  Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease.

Authors:  I Zerr; K Kallenberg; D M Summers; C Romero; A Taratuto; U Heinemann; M Breithaupt; D Varges; B Meissner; A Ladogana; M Schuur; S Haik; S J Collins; Gerard H Jansen; G B Stokin; J Pimentel; E Hewer; D Collie; P Smith; H Roberts; J P Brandel; C van Duijn; M Pocchiari; C Begue; P Cras; R G Will; P Sanchez-Juan
Journal:  Brain       Date:  2009-09-22       Impact factor: 13.501

10.  The radiological findings of hypoglycemic encephalopathy: A case report with high b value DWI analysis.

Authors:  Shan Ren; Zhigang Chen; Ming Liu; Zhiqun Wang
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.